Viewing Study NCT01382160


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-26 @ 1:26 AM
Study NCT ID: NCT01382160
Status: COMPLETED
Last Update Posted: 2025-12-22
First Post: 2010-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
Sponsor: University Hospital, Tours
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: PHRI10-DM/AFORA
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators